Immunocytological and preliminary immunohistochemical studies of prothymosin α, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 11, 2008, Pages 1023-1031

  Klimentzou, Persefoni ^a   Drougou, Angeliki ^b   Fehrenbacher, Birgit ^c   Schaller, Martin ^c   Voelter, Wolfgang ^d   Barbatis, Calypso ^b   Paravatou Petsotas, Maria ^a   Livaniou, Evangelia ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b RED CROSS HOSPITAL   (Greece)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cancer prostate tissues; ELISA; Immunocytology; Immunohistochemistry; Polyclonal antibody; Prothymosin ; Western blot

Indexed keywords

ANTIBODY; ANTIBODY G; ANTIBODY Y; KEYHOLE LIMPET HEMOCYANIN; POLYCLONAL ANTIBODY; POLYPEPTIDE; PROTHYMOSIN ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CELL ASSAY; CELL NUCLEUS; CONTROLLED STUDY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HEN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNIZATION; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL RESEARCH; NEW ZEALAND; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RABBIT; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTIBODIES; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; CHICKENS; FIBROBLASTS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; PROTEIN PRECURSORS; RABBITS; THYMOSIN;

ORYCTOLAGUS CUNICULUS;

EID: 54349083780     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2008.950956     Document Type: Article

References (41)

1. Avrameas S (1969) Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies. Immunochemistry 6:43-52
2. Bustelo XR, Otero A, Gomez-Marquez J, Freire M (1991) Expression of the rat prothymosin alpha gene during T-lymphocyte proliferation and liver regeneration. J Biol Chem 266:1443-1447
3. Carlander D, Stalberg J, Larsson A (1999) Chicken antibodies: a clinical chemistry perspective. Ups J Med Sci 104:179-189
4. Cordero OJ, Maurer HR, Nogueira M (1997) Novel approaches to immunotherapy using thymic peptides. Immunol Today 18:10-13
5. Costopoulou D, Leondiadis L, Czarnecki J, Ferderigos N, Ithakissios DS, Livaniou E, Evangelatos GP (1998) Direct ELISA method for the specific determination of prothymosin alpha in human specimens. J Immunoassay 19:295-316
6. Costopoulou D, Livaniou E, Leondiadis L, Apostolikas N, Czarnecki J, Ithakissios DS, Evangelatos GP (1997) Development of an antiserum against the C-terminal fragment [101-109] of prothymosin alpha and its potential application to ELISA direct serum measurements and to immunohistochemical studies. Int J Thymol 5:437-442
7. Dominguez F, Magdalena C, Cancio E, Roson E, Paredes J, Loidi L, Zalvide J, et al. (1993) Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer. Eur J Cancer 29A:893-897
8. Enkemann SA, Wang RH, Trumbore MW, Berger SL (2000a) Functional discontinuities in prothymosin alpha caused by caspase cleavage in apoptotic cells. J Cell Physiol 182:256-268
9. Enkemann SA, Ward RD, Berger SL (2000b) Mobility within the nucleus and neighboring cytosol is a key feature of prothymosin-alpha. J Histochem Cytochem 48:1341-1355
10. Evstafieva AG, Belov GA, Kalkum M, Chichkova NV, Bogdanov AA, Agol VI, Vartapetian AB (2000) Prothymosin alpha fragmentation in apoptosis. FEBS Lett 467:150-154
11. Evstafieva AG, Belov GA, Rubtsov YP, Kalkum M, Joseph B, Chichkova NV, Sukhacheva EA, et al. (2003) Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha. Exp Cell Res 284:211-223
12. Freire M, Diaz-Jullien C, Covelo G (2002) Developments in prothymosin α research. In: Pandalai SG, ed. Recent Research and Development in Proteins, vol 1. Kerala, India, Transworld Research Network, 257-276
13. Gast K, Damaschun H, Eckert K, Schulze-Forster K, Maurer HR, Muller-Frohne M, Zirwer D, et al. (1995) Prothymosin alpha: a biologically active protein with random coil conformation. Biochemistry 34:13211-13218
14. Hannappel E, Huff T (2003) The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. Vitam Horm 66:257-296
15. Haritos AA, Goodall GJ, Horecker BL (1984) Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus. Proc Natl Acad Sci USA 81:1008-1011
16. Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, Kofron J, Donnelly J, et al. (2003) Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299:223-226
17. Karapetian RN, Evstafieva AG, Abaeva IS, Chichkova NV, Filonov GS, Rubtsov YP, Sukhacheva EA, et al. (2005) Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol Cell Biol 25:1089-1099
18. Karetsou Z, Martic G, Tavoulari S, Christoforidis S, Wilm M, Gruss C, Papamarcaki T (2004) Prothymosin alpha associates with the oncoprotein SET and is involved in chromatin decondensation. FEBS Lett 577:496-500
19. Klimentzou P, Paravatou-Petsotas M, Zikos C, Beck A, Skopeliti M, Czarnecki J, Tsitsilonis O, et al. (2006) Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha. Peptides 27:183-193
20. Kobayashi T, Wang T, Maezawa M, Kobayashi M, Ohnishi S, Hatanaka K, Hige S, et al. (2006) Overexpression of the oncoprotein prothymosin alpha triggers a p53 response that involves p53 acetylation. Cancer Res 66:3137-3144
21. Lal A, Kawai T, Yang X, Mazan-Mamczarz K, Gorospe M (2005) Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha. EMBO J 24:1852-1862
22. Letsas KP, Frangou-Lazaridis M, Skyrlas A, Tsatsoulis A, Malamou-Mitsi V (2005) Transcription factor-media ted proliferation and apoptosis in benign and malignant thyroid lesions. Pathol Int 55:694-702
23. Leys CM, Nomura S, LaFleur BJ, Ferrone S, Kaminishi M, Montgomery E, Goldenring JR (2007) Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. Surgery 141:41-50
24. Livaniou E, Mihelic M, Evangelatos GP, Haritos A, Voelter W (1992) A thymosin β4 ELISA using an antibody against the N terminal fragment thymosin β4[1-14]. J Immunol Methods 148:9-14
25. Loidi L, Vidal A, Zalvide JB, Puente JL, Reyes F, Dominguez F (1997) Development of ELISA to estimate thymosin alpha1, the N terminus of prothymosin alpha, in human tumors. Clin Chem 43:59-63
26. Mitani M, Kuwabara Y, Kawamura H, Sato A, Hattori K, Fujii Y (2000) Significance of plasma thymosin alpha1 measurements in gastric cancer patients. World J Surg 24:455-458
27. Panneerselvam C, Haritos AA, Caldarella J, Horecker BL (1987) Prothymosin alpha in human blood. Proc Natl Acad Sci USA 84:4465-4469
28. Papamarcaki T, Tsolas O (1994) Prothymosin alpha binds to histone H1 in vitro. FEBS Lett 345:71-75
29. Rodriguez P, Vinuela JE, Alvarez-Fernandez L, Buceta M, Vidal A, Dominguez F, Gomez-Marquez J (1998) Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells. Biochem J 331:753-761
30. Sarandeses CS, Covelo G, Diaz-Jullien C, Freire M (2003) Prothymosin alpha is processed to thymosin alpha 1 and thymosin alpha 11 by a lysosomal asparaginyl endopeptidase. J Biol Chem 278:13286-13293
31. Schade R, Behn I, Erhard M, Hlinak A, Staak C (2001) Chicken Egg Yolk Antibodies, Production and Application. IgY-Technology. Berlin, Springer-Verlag
32. Schade R, Calzado EG, Sarmiento R, Chacana PA, Porankiewicz-Asplund J, Terzolo HR (2005) Chicken egg yolk antibodies (IgY-technology): a review of progress in production and use in research and human and veterinary medicine. Altern Lab Anim 33:129-154
33. Skopeliti M, Voutsas IF, Klimentzou P, Tsiatas ML, Beck A, Bamias A, Moraki M, et al. (2006) The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients. Cancer Immunol Immunother 55:1247-1257
34. Staehli C, Takacs B, Kocyba C (1983) Monoclonal antibodies to thymosin a1. Mol Immunol 20:1095-1097
35. Sukhacheva EA, Evstafieva AG, Fateeva TV, Shakulov VR, Efimova NA, Karapetian RN, Rubtsov YP, et al. (2002) Sensing prothymosin alpha origin, mutations and conformation with monoclonal antibodies. J Immunol Methods 266:185-196
36. Suzuki S, Takahashi S, Takahashi S, Takeshita K, Hikosaka A, Wakita T, Nishiyama N, et al. (2006) Expression of prothymosin alpha is correlated with development and progression in human prostate cancers. Prostate 66:463-469
37. Tini M, Jewell UR, Camenisch G, Chilov D, Gassmann M (2002) Generation and application of chicken egg-yolk antibodies. Comp Biochem Physiol A Mol Integr Physiol 131:569-574
38. Tsitsiloni OE, Heimer E, Felix A, Yialouris PP, Vamvoukakis J, Voelter W, Haritos AA (1994) Radioimmunoassays for the C-terminus of prothymosin alpha and the N-terminus of parathymosin alpha for the measurement of the levels of alpha-thymosins in human cancer. J Immunol Methods 169:163-171
39. Vaitukaitis JL (1981) Production of antisera with small doses of immunogen: multiple intradermal injections. Methods Enzymol 73:46-52
40. Yialouris PP, Evangelatos GP, Soteriadis-Vlahos C, Heimer EP, Felix AM, Tsitsiloni OE, Haritos AA (1988) The identification of prothymosin alpha-like material in vertebrate lymphoid organs by a radioimmunoassay for the N-terminal decapeptide. J Immunol Methods 106:267-275
41. Zikos C, Livaniou E, Leondiadis L, Ferderigos N, Ithakissios DS, Evangelatos GP (2003) Comparative evaluation of four trityl-type amidomethyl polystyrene resins in Fmoc solid phase peptide synthesis. J Pept Sci 9:419-429